Number of the records: 1  

Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides

  1. 1.
    0480866 - ÚOCHB 2018 RIV US eng J - Journal Article
    Perlíková, Pavla - Hocek, Michal
    Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides.
    Medicinal Research Reviews. Roč. 37, č. 6 (2017), s. 1429-1460. ISSN 0198-6325. E-ISSN 1098-1128
    R&D Projects: GA ČR(CZ) GA16-00178S
    Grant - others:AV ČR(CZ) AP1501
    Program: Akademická prémie - Praemium Academiae
    Institutional support: RVO:61388963
    Keywords : antivirals * cytostatics * deazapurines * nucleosides * nucleotides
    OECD category: Organic chemistry
    Impact factor: 8.290, year: 2017
    http://onlinelibrary.wiley.com/doi/10.1002/med.21465/full

    7-Deazapurine (pyrrolo[2,3-d]pyrimidine) nucleosides are important analogues of biogenic purine nucleosides with diverse biological activities. Replacement of the N7 atom with a carbon atom makes the five-membered ring more electron rich and brings a possibility of attaching additional substituents at the C7 position. This often leads to derivatives with increased base-pairing in DNA or RNA or better binding to enzymes. Several types of 7-deazapurine nucleosides with potent cytostatic or cytotoxic effects have been identified. The most promising are 7-hetaryl-7-deazaadenosines, which are activated in cancer cells by phosphorylation and get incorporated both to RNA (causing inhibition of proteosynthesis) and to DNA (causing DNA damage). Mechanism of action of other types of cytostatic nucleosides, 6-hetaryl-7-deazapurine and thieno-fused deazapurine ribonucleosides, is not yet known. Many 7-deazaadenosine derivatives are potent inhibitors of adenosine kinases. Many types of sugar-modified derivatives of 7-deazapurine nucleosides are also strong antivirals. Most important are 2'-C-methylribo- or 2'-C-methyl-2'-fluororibonucleosides with anti-HCV activities (several compounds underwent clinical trials). Some underexplored areas of potential interest are also outlined.
    Permanent Link: http://hdl.handle.net/11104/0276543

     
    FileDownloadSizeCommentaryVersionAccess
    0480866.pdf31.3 MBPublisher’s postprintopen-access
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.